SweetValueLab
Write for us

Henry Schein, Inc. — Intrinsic Value & Fair Price

HSIC
NASDAQHealthcareMedical - DistributionCIK 0001000228henryschein.comAbout HSIC
Last close · Oct 16, 202686.38−0.61 (−0.70%)
Market cap$9.6B
Model value · DCF · Perpetuity growth · 5y
83.31
Henry Schein closed at $86.38 — overvalued by 4% vs model.
43.91the model's range269.83

DCF · Perpetuity growth · 5y leads for a mature, steady company — positive operating income and three years of positive free cash flow. From a five-year discounted cash flow.

Other models
4.86 – 122.40
Wall St. target
97.50 11% below
Above model, 1y
16 of 20 days

Price and model value

Embed this card

HSIC's close against its model value, as a 420×168 card for your own page. It updates nightly with this site and links back here.

Free to embed; keep the attribution link.
Loading chart…
What the marks mean
Daily close

Research on HSIC

No posts on HSIC yet.
Studied HSIC from its filings? Guest posts are reviewed before they go live.Write about HSIC →

How it is valued

Valued asMature & stable
Low/slowing growth (~3% recent)Thin margins (3.0% net margin)Highly cyclical earningsStrong FCF yield (6.0%)
What growth the price implies: the reverse DCF

Key figures

FY2025 · chosen for mature companies
P/E
26.4×
EV / EBITDA
12.5×
FCF yield
5.5%
Dividend yield, TTM
0.00%
Beta
0.84
Cost of capital (WACC)
7.60%
Full financials

Analyst actions

third-party, quoted
10-14Leerink Partners · target92.00
08-19BTIG · target110.00
08-06Barclays · target100.00
06-11BTIG · “Buy” from “Neutral”upgrade
Ratings, targets and estimates

Comparable companies

by business, not by industry label
1 more company lists HSIC as a comparable

The weekly

One email a week across every stock we cover: 13F filings, insider trades, earnings and new research. It covers the whole market, not just HSIC. No account.

About Henry Schein

Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.

CEO
Frederick Lowery
Headquarters
Melville, NY
Employees
25,000
IPO
1995-11-03
Full company profile

Model estimates for research reference only, not investment advice. Every model rests on assumptions that may not match what happens; the formulas are in how we value a stock.